Advanced Cell Technology Corp.

Geron receives favorable ruling in nuclear-transfer patent interference

Published in Healthcare Mergers, Acquisitions and Ventures Week, April 17th, 2004

Geron Corp. (GERN) announced that the board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office has issued a decision on motions filed in the patent interference proceeding between Geron and Advanced Cell Technology Corp. of Worcester, Massachusetts (ACT).

The decision finds all claims in the issued ACT nuclear-transfer patent to be unpatentable.

All motions filed by ACT were denied, including motions attacking the patentability of Geron's claims.

This proceeding is one of two interferences that have so far been declared by the Patent Office, at Geron's request, involving patents licensed to ACT. The patent...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2004-04-17)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Accelr8 Technology Corporation
Diagnostics company reports loss of $0.04 per share
Altana AG
Pharmaceutical company's sales increased 5% in 2003
Antares Pharma, Inc.
U.S. patent issued on Valeo, a needle-free injector device
AxioMed Spine Corp.
Spinal implant device firm names David K. Floyd president, CEO
Barr Pharmaceuticals, Inc.
Pharmaceutical company announces stock split distribution
Bayer Group
Pharmaceutical firm aims to increase EBITDA margin
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry